Literature DB >> 30156545

Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndrome.

Alessia Alunno1, Elena Bartoloni1, Valentina Valentini1, Giuliana Maria Concetta La Paglia1, Eleonora Valentini1, Maria Comasia Leone1, Elisa Marcucci1, Giacomo Cafaro1, Angelo Francesco Bonifacio1, Filippo Luccioli1, Roberto Gerli2.   

Abstract

Mucosal dryness is a key clinical feature in primary Sjögren's syndrome (pSS) and its assessment relies on both objective measurement of residual secretion and subjective symptoms reported by patients. However, while the objective assessment and grading of glandular dysfunction can be easily performed, the spectrum of clinical symptoms encompassed by the terms 'dry eye' and 'dry mouth' is wide and heterogeneous. Therefore, patient reported outcomes (PROs) for dryness in pSS poorly correlate with the amount of glandular secretion. In addition, subjective dryness is not correlated with the severity of systemic disease and severely affects the patient quality of life even in presence of active extraglandular manifestations. The purpose of this review article is to provide an overview of glandular dysfunction in pSS as well as the impact of discrepancy between objective assessment, subjective symptom and extraglandular disease activity on disease management.

Entities:  

Mesh:

Year:  2018        PMID: 30156545

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra®) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease.

Authors:  John A Hovanesian; Kelly K Nichols; Mitchell Jackson; James Katz; Arthur Chan; Mrudula B Glassberg; Brigitte Sloesen; Caroline Korves; Catherine Nguyen; Annie Syntosi
Journal:  Clin Ophthalmol       Date:  2021-03-08

2.  Editorial: Management of Sjögren's Syndrome.

Authors:  Alessia Alunno; Clio P Mavragani; Francesco Carubbi
Journal:  Front Med (Lausanne)       Date:  2022-01-13

3.  The interplay between cognition, depression, anxiety, and sleep in primary Sjogren's syndrome patients.

Authors:  Radjiv Goulabchand; Elodie Castille; Audrey Gabelle; Philippe Guilpain; Sophie Navucet; Damien Etchecopar-Etchart; Aurélie Matos; Alexandre Maria; Laure Anne Gutierrez; Alain Le Quellec; Nicolas Menjot de Champfleur
Journal:  Sci Rep       Date:  2022-08-01       Impact factor: 4.996

4.  Sjögren's syndrome.

Authors:  Fiona André; Barbara C Böckle
Journal:  J Dtsch Dermatol Ges       Date:  2022-07-01       Impact factor: 5.231

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.